These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34856990)

  • 21. Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion.
    He WT; Wan H; Hu L; Chen P; Wang X; Huang Z; Yang ZH; Zhong CQ; Han J
    Cell Res; 2015 Dec; 25(12):1285-98. PubMed ID: 26611636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Systemic inflammatory markers in age-associated cognitive impairment and Alzheimer's disease].
    Kliushnik TP; Androsova LV; Mikhaylova NM; Kolykhalov IV; Zozulya SA; Dupin AM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(7):74-79. PubMed ID: 28805765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impairing Gasdermin D-mediated pyroptosis is protective against retinal degeneration.
    Sekar R; Wooff Y; Cioanca AV; Kurera M; Ngo C; Man SM; Natoli R
    J Neuroinflammation; 2023 Oct; 20(1):239. PubMed ID: 37864169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of melatonin in amyloid beta-induced inflammation mediated by inflammasome signaling in neuronal cell lines.
    Nopparat C; Boontor A; Kutpruek S; Govitrapong P
    Sci Rep; 2023 Oct; 13(1):17841. PubMed ID: 37857668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson's disease.
    Fan Z; Pan YT; Zhang ZY; Yang H; Yu SY; Zheng Y; Ma JH; Wang XM
    J Neuroinflammation; 2020 Jan; 17(1):11. PubMed ID: 31915018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-181c-5p suppresses neuronal pyroptosis via NLRP1 in Alzheimer's disease.
    Wang T; Long Q; Hu Y; Yang Y; Li X; Wei H
    Behav Brain Res; 2023 Jun; 447():114387. PubMed ID: 37003492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's disease.
    Parker DC; Mielke MM; Yu Q; Rosenberg PB; Jain A; Lyketsos CG; Fedarko NS; Oh ES
    Int J Geriatr Psychiatry; 2013 Feb; 28(2):149-54. PubMed ID: 22539447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of AIM2 inflammasome-induced pyroptosis on acute gouty arthritis and asymptomatic hyperuricemia patients.
    Chu J; Tian J; Li P; Fu D; Guo L; Sun R
    Front Immunol; 2024; 15():1386939. PubMed ID: 39100670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of Dysregulated Proinflammatory Cytokines and Cognitive Dysfunction in Late-Life Depression and Amnestic Mild Cognitive Impairment.
    Nie J; Fang Y; Chen Y; Aidina A; Qiu Q; Zhao L; Liu X; Sun L; Li Y; Zhong C; Li Y; Li X
    Front Immunol; 2021; 12():803633. PubMed ID: 35069588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hard Test Your Memory. Evaluation of a short cognitive test to detect mild Alzheimer's disease and amnestic mild cognitive impairment.
    Brown JM; Wiggins J; Dong H; Harvey R; Richardson F; Hunter K; Dawson K; Parker RA
    Int J Geriatr Psychiatry; 2014 Mar; 29(3):272-80. PubMed ID: 23929807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validity of the Georgian Montreal Cognitive Assessment for the Screening of Mild Cognitive Impairment and Dementia.
    Janelidze M; Mikeladze N; Bochorishvili N; Dzagnidze A; Kapianidze M; Mikava N; Khatiashvili I; Kakhiani D; Mirvelashvili E; Shiukashvili N; Nadareishvili Z
    Am J Alzheimers Dis Other Demen; 2017 Feb; 32(1):36-40. PubMed ID: 27909150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer History Avoids the Increase of Senescence Markers in Peripheral Cells of Amnestic Mild Cognitive Impaired Patients.
    SanMartín CD; Salech F; Ponce DP; Concha-Cerda J; Romero-Hernández E; Liabeuf G; Rogers NK; Murgas P; Bruna B; More J; Behrens MI
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of the total flavonoids from Clinopodium chinense against LPS-induced mice endometritis by inhibiting NLRP3 inflammasome-mediated pyroptosis.
    Li L; Qi J; Tao H; Wang L; Wang L; Wang N; Huang Q
    J Ethnopharmacol; 2023 Aug; 312():116489. PubMed ID: 37054825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shiga Toxin/Lipopolysaccharide Activates Caspase-4 and Gasdermin D to Trigger Mitochondrial Reactive Oxygen Species Upstream of the NLRP3 Inflammasome.
    Platnich JM; Chung H; Lau A; Sandall CF; Bondzi-Simpson A; Chen HM; Komada T; Trotman-Grant AC; Brandelli JR; Chun J; Beck PL; Philpott DJ; Girardin SE; Ho M; Johnson RP; MacDonald JA; Armstrong GD; Muruve DA
    Cell Rep; 2018 Nov; 25(6):1525-1536.e7. PubMed ID: 30404007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minocycline alleviates NLRP3 inflammasome-dependent pyroptosis in monosodium glutamate-induced depressive rats.
    Yang F; Zhu W; Cai X; Zhang W; Yu Z; Li X; Zhang J; Cai M; Xiang J; Cai D
    Biochem Biophys Res Commun; 2020 Jun; 526(3):553-559. PubMed ID: 32245616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HSP70 alleviates sepsis-induced cardiomyopathy by attenuating mitochondrial dysfunction-initiated NLRP3 inflammasome-mediated pyroptosis in cardiomyocytes.
    Song C; Zhang Y; Pei Q; Zheng L; Wang M; Shi Y; Wu S; Ni W; Fu X; Peng Y; Zhang W; Yao M
    Burns Trauma; 2022; 10():tkac043. PubMed ID: 36439706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyroptosis in neutrophils: Multimodal integration of inflammasome and regulated cell death signaling pathways.
    Dubyak GR; Miller BA; Pearlman E
    Immunol Rev; 2023 Mar; 314(1):229-249. PubMed ID: 36656082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of the Montreal Cognitive Assessment Thai Version to Discriminate Amnestic Mild Cognitive Impairment from Alzheimer's Disease and Healthy Controls: Machine Learning Results.
    Hemrungrojn S; Tangwongchai S; Charoenboon T; Panasawat M; Supasitthumrong T; Chaipresertsud P; Maleevach P; Likitjaroen Y; Phanthumchinda K; Maes M
    Dement Geriatr Cogn Disord; 2021; 50(2):183-194. PubMed ID: 34325427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a 6-month cognitive intervention program on brain metabolism in amnestic mild cognitive impairment and mild Alzheimer's disease.
    Förster S; Buschert VC; Buchholz HG; Teipel SJ; Friese U; Zach C; la Fougere C; Rominger A; Drzezga A; Hampel H; Bartenstein P; Buerger K
    J Alzheimers Dis; 2011; 25(4):695-706. PubMed ID: 21498904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Tan YJ; Ng ASL; Vipin A; Lim JKW; Chander RJ; Ji F; Qiu Y; Ting SKS; Hameed S; Lee TS; Zeng L; Kandiah N; Zhou J
    J Alzheimers Dis; 2017; 58(2):413-423. PubMed ID: 28453482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.